House Dems call on the FTC to investigate potential collusion among top three insulin manufacturers
Striking while the iron is hot, six House Democrats sent a letter Thursday to the acting chairwoman of the FTC (10 days after the FTC said it would crack down on pharma mergers), calling for an investigation into the potential collusion of insulin market leaders Eli Lilly, Sanofi and Novo Nordisk.
Led by Rep. Katie Porter of California, the letter notes that the three companies raised the prices of their insulins in lockstep, and between 2012 and 2016, the price of insulin almost doubled. Sen. Bernie Sanders (I-VT) and the late Rep. Elijah Cummings of Maryland sent a letter to the FTC raising similar charges of collusion among the same three companies in 2016.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.